DK1232392T3 - Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring - Google Patents

Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring

Info

Publication number
DK1232392T3
DK1232392T3 DK00967861T DK00967861T DK1232392T3 DK 1232392 T3 DK1232392 T3 DK 1232392T3 DK 00967861 T DK00967861 T DK 00967861T DK 00967861 T DK00967861 T DK 00967861T DK 1232392 T3 DK1232392 T3 DK 1232392T3
Authority
DK
Denmark
Prior art keywords
complex
mab
fragments
mammal
detecting
Prior art date
Application number
DK00967861T
Other languages
Danish (da)
English (en)
Inventor
Christian Reiter
Gerhard Cullmann
Petra Heppner
Achim Ringeis
Heidemarie Mueller
Eva Haindl
Original Assignee
Connex Ges Zur Optimierung Von
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27439941&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1232392(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Connex Ges Zur Optimierung Von filed Critical Connex Ges Zur Optimierung Von
Application granted granted Critical
Publication of DK1232392T3 publication Critical patent/DK1232392T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/908—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/98—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK00967861T 1999-10-12 2000-10-12 Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring DK1232392T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP99120351 1999-10-12
EP00105592 2000-03-16
EP00107028 2000-03-31
EP00110110 2000-05-10
PCT/EP2000/010058 WO2001027613A2 (de) 1999-10-12 2000-10-12 Verbessertes verfahren zum nachweis von säure-resistenten mikroorganismen im stuhl

Publications (1)

Publication Number Publication Date
DK1232392T3 true DK1232392T3 (da) 2003-07-28

Family

ID=27439941

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00967861T DK1232392T3 (da) 1999-10-12 2000-10-12 Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring

Country Status (16)

Country Link
US (1) US7129053B1 (pt)
EP (2) EP1232392B2 (pt)
JP (2) JP2003511698A (pt)
CN (1) CN1382259A (pt)
AT (1) ATE236398T1 (pt)
AU (2) AU7787100A (pt)
BR (1) BR0014734A (pt)
CA (1) CA2387473C (pt)
DE (1) DE50001665D1 (pt)
DK (1) DK1232392T3 (pt)
ES (1) ES2194782T5 (pt)
IL (1) IL149062A0 (pt)
PT (1) PT1232392E (pt)
SI (1) SI1232392T1 (pt)
TR (1) TR200201006T2 (pt)
WO (2) WO2001027613A2 (pt)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1195869C (zh) * 1999-10-29 2005-04-06 若素制药株式会社 单克隆抗体、杂交瘤、免疫测定法和诊断试剂盒
JP3504633B2 (ja) 1999-10-29 2004-03-08 わかもと製薬株式会社 ヘリコバクター・ピロリへの感染を判定する検査方法及び検査試薬
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US6706474B1 (en) 2000-06-27 2004-03-16 Board Of Trustees Of The University Of Illinois Nucleic acid enzyme biosensors for ions
WO2002014541A1 (en) * 2000-08-11 2002-02-21 Wakamoto Pharmaceutical Co., Ltd. Method of examining infection with helicobacter pylori and diagnostic kit
US20070053895A1 (en) * 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
JP4763149B2 (ja) * 2001-05-10 2011-08-31 わかもと製薬株式会社 ヘリコバクター・ピロリへの感染を判定する検査方法
FI118061B (fi) 2001-09-24 2007-06-15 Beanor Oy Menetelmä ja bioanturi analyysiä varten
FI115166B (fi) 2001-12-31 2005-03-15 Biofons Oy Diagnostisia menetelmiä
GB0210121D0 (en) 2002-05-02 2002-06-12 Celltech R&D Ltd Biological products
EP1507556B1 (en) 2002-05-02 2016-07-27 Wyeth Holdings LLC Calicheamicin derivative-carrier conjugates
US7534560B2 (en) 2002-05-10 2009-05-19 The Board Of Trustees Of The University Of Illinois Simple catalytic DNA biosensors for ions based on color changes
US6890719B2 (en) 2002-05-10 2005-05-10 The Board Of Trustess Of The University Of Illinois Fluorescence based biosensor
US7612185B2 (en) 2003-03-07 2009-11-03 The Board Of Trustees Of The University Of Illinois Nucleic acid biosensors
KR20060069825A (ko) * 2003-08-01 2006-06-22 제넨테크, 인크. 제한된 다양성을 갖는 항체 ｃｄｒ 폴리펩티드 서열
DK1698698T3 (da) * 2003-12-05 2014-05-12 Fuso Pharmaceutical Ind Cytolethaldistenderende toksingener som mål for detektering af campylobacterbakterier
EP1697399B1 (en) * 2003-12-12 2016-11-23 GOVERNMENT OF THE UNITED STATES OF AMERICA, as repr. by THE SECR. OF THE DEPT. OF HEALTH AND HUMAN SERVICES AND HIS SUCCESSORS A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
US7485419B2 (en) 2004-01-13 2009-02-03 The Board Of Trustees Of The University Of Illinois Biosensors based on directed assembly of particles
JP4672263B2 (ja) * 2004-01-27 2011-04-20 デンカ生研株式会社 簡便な検出法、検出装置及び検出キットとその製法
EP1686378B1 (en) * 2005-01-28 2010-11-17 DNT Scientific Research, LLC Fluid flow diffuser for immunological testing devices and method
LT3264094T (lt) 2005-04-04 2021-04-12 Biogen Ma Inc. Imuninio atsako į terapijos agentą įvertinimo būdai
US7892734B2 (en) 2005-08-11 2011-02-22 The Board Of Trustees Of The University Of Illinois Aptamer based colorimetric sensor systems
AU2012244244B2 (en) * 2005-08-11 2015-08-27 Arpi Matossian-Rogers TCR-V-beta related peptides for treatment and diagnosis of autoimmune disease
GB2429013C (en) * 2005-08-11 2012-11-28 Arpi Matossian-Rogers Peptides for treatment and diagnosis of autoimmunedisease
CA2620079A1 (en) * 2005-08-23 2007-03-01 Paul C. Harris Multi-directional immunochromatographic assays
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
EP4276469A3 (en) 2006-02-28 2024-01-17 Biogen MA Inc. Methods of treating inflammatory and autoimmune diseases with natalizumab
EA016626B1 (ru) 2006-03-03 2012-06-29 Элан Фамэсьютикэлс, Инк. Способ лечения натализумабом воспалительного и/или аутоиммунного заболевания (варианты)
WO2007109500A1 (en) * 2006-03-16 2007-09-27 The Board Of Trustees Of The University Of Illinois Lateral flow devices
WO2008089248A2 (en) 2007-01-19 2008-07-24 The Board Of Trustees Of The University Of Illinois Amphiphilic substances and triggered liberation from lipid vesicles
US8058415B2 (en) 2007-04-24 2011-11-15 The Board Of Trustees Of The University Of Illinois Aptamer- and nucleic acid enzyme-based systems for simultaneous detection of multiple analytes
ES2374686T3 (es) 2007-05-14 2012-02-21 Historx, Inc. Separación en compartimentos por caracterización de píxel usando agrupamiento de datos de imágenes.
CA2690633C (en) 2007-06-15 2015-08-04 Historx, Inc. Method and system for standardizing microscope instruments
US8409800B2 (en) 2007-07-16 2013-04-02 The Board Of Trustees Of The University Of Illinois Nucleic acid based fluorescent sensor for copper detection
US8568690B2 (en) 2007-07-31 2013-10-29 The Board Of Trustees Of The University Of Illinois MRI contrast agents and high-throughput screening by MRI
CA2604317C (en) 2007-08-06 2017-02-28 Historx, Inc. Methods and system for validating sample images for quantitative immunoassays
CA2596204C (en) 2007-08-07 2019-02-26 Historx, Inc. Method and system for determining an optimal dilution of a reagent
US8367416B2 (en) 2007-08-10 2013-02-05 The Board Of Trustees Of The University Of Illinois Nucleic acid based fluorescent sensor for mercury detection
WO2009029810A1 (en) 2007-08-31 2009-03-05 Historx, Inc. Automatic exposure time selection for imaging tissue
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
WO2010002972A1 (en) 2008-07-01 2010-01-07 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
CA2737116C (en) 2008-09-16 2019-01-15 Historx, Inc. Reproducible quantification of biomarker expression
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
US8062893B2 (en) 2008-10-10 2011-11-22 The Board Of Trustees Of The University Of Illinois Fluorescent sensor for mercury
BRPI1007378A2 (pt) 2009-01-06 2020-08-18 Curemark Llc composições e métodos para o tratamento ou prevenção de infecções por staphylococcus aureus e para a erradicação ou redução de staphylococcus aureus sobre superfícies.
EP2947100B1 (en) 2009-01-06 2019-05-08 Galenagen, LLC Oral compositions for the treatment or the prevention of infections by E. Coli
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
CA2776756A1 (en) 2009-10-11 2011-04-14 Biogen Idec Ma Inc. Anti-vla-4 related assays
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
US11287423B2 (en) 2010-01-11 2022-03-29 Biogen Ma Inc. Assay for JC virus antibodies
IN2012DN06139A (pt) 2010-01-11 2015-09-18 Biogen Idec Inc
US8815156B2 (en) 2010-07-19 2014-08-26 Andalyze, Inc. Sensor housing and reagent chemistry
HUE050873T2 (hu) 2011-04-21 2021-01-28 Curemark Llc Vegyületek neuropszichiátriai rendellenességek kezelésére
CN102539424B (zh) * 2011-12-23 2013-11-20 李雄 一种pH值乙醇法舌苔快速尿素酶的检测方法及试剂盒
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
CN102980884A (zh) * 2012-11-29 2013-03-20 江苏创生生物技术有限公司 胃黏膜样品中幽门螺旋杆菌的化学发光免疫测定法
US10119976B2 (en) 2013-05-28 2018-11-06 Biogen Ma Inc. Method of assessing risk of PML
MY192062A (en) 2014-12-05 2022-07-25 Memorial Sloan Kettering Cancer Center Chimeric antigen receptors targeting fc receptor-like 5 and uses thereof
US10768172B2 (en) 2015-10-21 2020-09-08 Redcoat Solutions, Inc. Anti-bed bug monoclonal antibodies and methods of making and uses thereof
DK3370515T3 (da) 2015-10-21 2022-05-02 Redcoat Solutions Inc Anordning til påvisning af væggelus
AU2016362402A1 (en) * 2015-12-04 2018-06-28 Eureka Therapeutics, Inc. Antibodies targeting Fc receptor-like 5 and methods of use
WO2019187271A1 (ja) 2018-03-30 2019-10-03 株式会社バイオメディカル研究所 検査キットおよび検査方法
CN111499751B (zh) * 2020-05-06 2021-03-19 云南省农业科学院园艺作物研究所 一种用于检测白菜过氧化氢酶的单克隆抗体及其应用
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
CN113388616B (zh) * 2021-07-27 2022-04-26 中国海洋大学 特异性结合幽门螺旋杆菌的核酸适配体、生物元件、生物传感器及检测方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE195022T1 (de) 1987-04-27 2000-08-15 Unilever Nv Spezifische bindungstestverfahren
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
US5607863A (en) * 1991-05-29 1997-03-04 Smithkline Diagnostics, Inc. Barrier-controlled assay device
WO1993016695A1 (en) * 1992-02-21 1993-09-02 Ciba-Geigy Ag Brofaromine as an agent for treating post-traumatic stress
JP3448071B2 (ja) * 1992-03-24 2003-09-16 ロート製薬株式会社 糞便中ヘモグロビン検出用装置
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
SE9600949D0 (sv) * 1996-03-12 1996-03-12 Stefan Svenson Method of diagnosing a mycobacterial disease and immunoassay kit
US5932430A (en) * 1996-05-09 1999-08-03 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
US5716791A (en) 1996-05-09 1998-02-10 Meridian Diagnostics, Inc. Immunoassay for H. pylori in fecal specimens
IT1289578B1 (it) * 1996-12-06 1998-10-15 Sanitaria Scaligera Spa Immunopurificazione di un antigene dall'apparente peso molecolare di 16 +- 2 kda dell' helicobacter pylori e metodi per la sua
CA2224551A1 (en) * 1998-02-25 1999-08-25 Alex Hongsheng Chang A quick in situ diagnostic method for detecting alimentary diseases
AU3458299A (en) * 1998-03-31 1999-10-18 United States Of America, As Represented By The Secretary Of Agriculture, The Monoclonal antibodies against (campylobacter jejuni) and (campylobacter coli) outer membrane antigens
AU1157100A (en) * 1998-10-29 2000-05-22 Connex Gmbh Detection of acid-resistant micro-organisms in a stool
US6433728B1 (en) 1999-01-22 2002-08-13 Lear Automotive Dearborn, Inc. Integrally molded remote entry transmitter

Also Published As

Publication number Publication date
EP1232392B2 (de) 2014-04-02
WO2001027612A2 (de) 2001-04-19
WO2001027612A3 (de) 2001-10-11
PT1232392E (pt) 2003-08-29
ES2194782T3 (es) 2003-12-01
EP1232392A1 (de) 2002-08-21
EP1232392B1 (de) 2003-04-02
ES2194782T5 (es) 2014-08-20
EP1336850A1 (de) 2003-08-20
BR0014734A (pt) 2002-06-18
SI1232392T1 (en) 2003-10-31
CA2387473C (en) 2010-02-02
DE50001665D1 (de) 2003-05-08
IL149062A0 (en) 2002-11-10
AU1137301A (en) 2001-04-23
WO2001027613A3 (de) 2001-10-18
CA2387473A1 (en) 2001-04-19
TR200201006T2 (tr) 2002-11-21
AU7787100A (en) 2001-04-23
US7129053B1 (en) 2006-10-31
JP2003511697A (ja) 2003-03-25
CN1382259A (zh) 2002-11-27
WO2001027613A2 (de) 2001-04-19
JP2003511698A (ja) 2003-03-25
ATE236398T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
DK1125130T3 (da) Påvisning af syreresistente mikroorganismer i afföringen
FI970301A (fi) Spesifisen immunoglobuliinin määrittäminen käyttäen useampaa antigeenia
WO2001009190A3 (en) Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
KR910021585A (ko) 알쯔하이머병의 진단 분석법
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
JP2019015736A5 (pt)
EP0310132A3 (en) Immunoassay utilizing igg capture antibody and multiple monoclonal antibody detection system
EP3306319B1 (en) Test object detection method, and immunoassay instrument and monoclonal antibody for same
ES2131279T3 (es) Inmunoensayo de tipo sandwich para n-peptido.
DK1257823T3 (da) Fremgangsmåde til påvisning af Helicobacter pylori og heilmanii
KR880013013A (ko) 액체 샘플내 다가 항원의 정량시약 및 면역화학적 정량방법
EA200100287A1 (ru) Высокоаффинные антитела
CA2095735A1 (en) Monoclonal antibodies to hepatitis c virus and method for using same
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
WO2022054753A1 (ja) 敗血症原因細菌の免疫学的分析キット
YU164090A (sh) Postopek za dokazovanje analitov
ATE281471T1 (de) Antikörper-testbesteck zur bestimmung von amylin
Sohi et al. The use of camel antibodies in development of EGFRvIII enzyme-linked immunosorbent assay
ATE119672T1 (de) Diagnostischer test für pseudomonas aeruginosa infektionen.
BR9102727A (pt) Processo para a preparacao de um anticorpo monoclonal, anticorpos monoclonais, linha de celulas, processo para sua preparacao, processo para a determinacao imunologica de herbicidas de sulfonilureia, agente para determinacao imunologica, componente de copulacao e processo para a preparacao de um componente
JP2005220044A (ja) 抗ミティスモノクローナル抗体、それを産生する細胞株、抗ミティスモノクローナル抗体の作製方法、およびミティス検出キット
Avrameas Qualitative and Quantitative Immunoenzymatic Techniques
JP2002058476A (ja) 抗ソブリヌスモノクローナル抗体、およびそれを産生する細胞株またはそれを含むソブリヌス検出用キット